MX9300011A - 4,5-dihidrogeldanamicin y su hidroquinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. - Google Patents

4,5-dihidrogeldanamicin y su hidroquinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Info

Publication number
MX9300011A
MX9300011A MX9300011A MX9300011A MX9300011A MX 9300011 A MX9300011 A MX 9300011A MX 9300011 A MX9300011 A MX 9300011A MX 9300011 A MX9300011 A MX 9300011A MX 9300011 A MX9300011 A MX 9300011A
Authority
MX
Mexico
Prior art keywords
procedure
compounds
dihidrogeldanamicin
hydroquinone
contain
Prior art date
Application number
MX9300011A
Other languages
English (en)
Spanish (es)
Inventor
Walter P Cullen
Mark T Jefferson
Mikel P Moyer
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9300011A publication Critical patent/MX9300011A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
MX9300011A 1992-01-06 1993-01-05 4,5-dihidrogeldanamicin y su hidroquinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. MX9300011A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81723592A 1992-01-06 1992-01-06

Publications (1)

Publication Number Publication Date
MX9300011A true MX9300011A (es) 1993-12-01

Family

ID=25222638

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300011A MX9300011A (es) 1992-01-06 1993-01-05 4,5-dihidrogeldanamicin y su hidroquinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Country Status (15)

Country Link
JP (1) JPH06510913A (fr)
KR (1) KR940703923A (fr)
CN (1) CN1074937A (fr)
AU (1) AU3225693A (fr)
BR (1) BR9207024A (fr)
CA (1) CA2127457A1 (fr)
CZ (1) CZ390592A3 (fr)
FI (1) FI943207A (fr)
HU (1) HU9401936D0 (fr)
IL (1) IL104289A0 (fr)
MX (1) MX9300011A (fr)
NO (1) NO942532L (fr)
PT (1) PT101169A (fr)
WO (1) WO1993014215A1 (fr)
ZA (1) ZA9333B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2794342B2 (ja) * 1993-06-29 1998-09-03 ファイザー・インク． 抗癌遺伝子剤および抗癌剤としてのアンサマイシン誘導体
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US6852496B1 (en) 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US6872715B2 (en) * 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
KR20040054692A (ko) 2001-09-24 2004-06-25 콘포마 세러퓨틱스 코포레이션 17-알릴 아미노 겔다나마이신 (17-ａａｇ) 및 기타안사마이신의 제조 방법
EP1923061A1 (fr) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Procédé pour la préparation de 17-allyl amino geldanamycine (17-AAG) et autres ansamycines
US7465718B2 (en) 2002-02-08 2008-12-16 Conforma Therapeutics Corporation Ansamycins having improved pharmacological and biological properties
TW200303363A (en) * 2002-02-25 2003-09-01 Upjohn Co Process to prepare and isolate geldanamycin
WO2005009345A2 (fr) 2003-06-13 2005-02-03 Kosan Biosciences, Inc. Composes de 2-desmethyl ansamycine
US6887993B1 (en) 2003-11-12 2005-05-03 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6875863B1 (en) 2003-11-12 2005-04-05 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6855705B1 (en) 2003-11-12 2005-02-15 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
EP1682514A4 (fr) 2003-11-12 2008-07-16 Kosan Biosciences Inc Composes 11-o-methylgeldanamycine
EP1689436A1 (fr) * 2003-11-26 2006-08-16 Entelos, Inc. TRAITEMENT DE LA POLYARTHRITE RHUMATOIDE AU MOYEN D'ANTAGONISTES DU FACTEUR a INDUCTIBLE PAR HYPOXIE
US7282493B2 (en) * 2003-12-23 2007-10-16 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
ZA200604863B (en) * 2003-12-23 2007-12-27 Infinity Pharmaceuticals Inc Analogs of benzoquinone-containing ansamycins for the treatment of cancer
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
NZ561939A (en) 2005-03-30 2011-03-31 Conforma Therapeutics Corp Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
ES2389740T3 (es) * 2006-11-09 2012-10-31 Bristol-Myers Squibb Company Nuevos compuestos y procedimientos para su producción
PE20081506A1 (es) 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
CN100500668C (zh) * 2006-12-19 2009-06-17 中国人民解放军军事医学科学院毒物药物研究所 格尔德霉素衍生物及其制备方法和制备药物的用途
EP2121957A4 (fr) 2007-01-26 2010-11-10 Kosan Biosciences Inc Macrolactames obtenus par biosynthèse modifiée
US20110034686A1 (en) * 2008-04-21 2011-02-10 Nitin Sopanrao Patil Process for Isolation and Purification of Geldanamycin
CN102245021B (zh) 2008-10-15 2014-09-17 无限药品公司 安莎霉素氢醌组合物
CN102030764B (zh) * 2010-11-12 2012-07-04 中国医学科学院医药生物技术研究所 4，5双氢噻嗪酮格尔德霉素及其制备方法
CN103305563B (zh) * 2013-06-14 2014-12-03 湖南农业大学 一种以链霉菌提制阿里沙霉素的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same

Also Published As

Publication number Publication date
FI943207A0 (fi) 1994-07-05
KR940703923A (ko) 1994-12-12
PT101169A (pt) 1994-03-31
FI943207A (fi) 1994-07-05
NO942532D0 (no) 1994-07-05
CA2127457A1 (fr) 1993-07-22
HU9401936D0 (en) 1994-09-28
BR9207024A (pt) 1995-12-05
CN1074937A (zh) 1993-08-04
JPH06510913A (ja) 1994-12-08
ZA9333B (en) 1994-07-05
CZ390592A3 (en) 1993-08-11
IL104289A0 (en) 1993-05-13
NO942532L (no) 1994-07-05
WO1993014215A1 (fr) 1993-07-22
AU3225693A (en) 1993-08-03

Similar Documents

Publication Publication Date Title
MX9300011A (es) 4,5-dihidrogeldanamicin y su hidroquinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
GT199900070A (es) Derivados de isotiazol, utiles como agentes anticancerosos.
AR026410A1 (es) ''2-aril-3-(heteroaril)-imidazo[1,2-a]pirimidinas sustituidas, y las composiciones y metodos farmaceuticos relacionados
AU561811B2 (en) Organic amide compounds derived from nitrogenous lipids
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
TNSN87021A1 (fr) Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
CA2096242A1 (fr) Composition anti-inflammatoire derivee de l'huile d'emou
ECSP003610A (es) Pirimidina-2,4,6 trionas inhibidores de metaloproteinas
MX9301835A (es) Composiciones alimenticias de derivado de vitamina d y metodo de uso.
ES2098004T3 (es) Peptidos derivados de trifluoro-metil-cetonas con una actividad inhibidora de la elastasa leucocitaria humana (hle), su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69114498D1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
DE69526353D1 (de) Immunologische aktivität der rhamnolipide
PA8485601A1 (es) Azalidas de 13 miembros y su uso como agentes antibioticos.
MX9204637A (es) Nuevos derivados de pirazina y procedimiento para su preparacion.
ATE284217T1 (de) Verwendung von sulphoquinovosyldiacylglycerols zur behandlung von entzündlichen hauterkrankungen
AR012546A1 (es) Utilizacion de al menos un compuesto seleccionado entre el grupo que comprende los sogaoles y los gingeroles para la preparacion de una composiciondesodorante, sogaol, extracto bruto y extracto purificado que contiene el sogaol y la composicion desodorante obtenida.
AU592593B2 (en) Improvements in relation to drug treatments
ATE90339T1 (de) Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel.
RU94046456A (ru) Новые аналоги витамина д, способ получения, фармацевтическая композиция, способ лечения
Rodgers et al. Investigations into the mechanism of immunosuppression caused by acute treatment with O, O, Sttrimethyl phosphorothioate. I. Characterization of the immune cell population affected
ATE87907T1 (de) Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel.
MX9401172A (es) Derivados fluorados de 4-aminoandrostadienona, procesamiento para su preparacion y composiciones farmaceuticas que los contienen.
SE9704590D0 (sv) Method of increasing the production and improving the quality of semen
CA2209205A1 (fr) Composition pharmaceutique renfermant un ester d'alpha-tocopherol et d'acide 9-cis retinoique pour le traitement de la leucemie
ES2054904T3 (es) Procedimiento para la preparacion de peptidos con actividad inhibidora de sistemas enzimaticos.